
Raymond J. Henley Iii
Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 2899, 1629, 1614, 1621 |
| Total Applications | 4324 |
| Issued Applications | 3034 |
| Pending Applications | 603 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6906273
[patent_doc_number] => 20050101668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions'
[patent_app_type] => utility
[patent_app_number] => 10/896888
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3308
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101668.pdf
[firstpage_image] =>[orig_patent_app_number] => 10896888
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/896888 | Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions | Jul 22, 2004 | Abandoned |
Array
(
[id] => 7127939
[patent_doc_number] => 20050059683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'A1 adenosine receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/897047
[patent_app_country] => US
[patent_app_date] => 2004-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11536
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10897047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/897047 | A1 adenosine receptor antagonists | Jul 21, 2004 | Issued |
Array
(
[id] => 7216779
[patent_doc_number] => 20050054667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Method of treating or inhibiting anti-arrhythmic events in male human patients'
[patent_app_type] => utility
[patent_app_number] => 10/894364
[patent_app_country] => US
[patent_app_date] => 2004-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5790
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10894364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/894364 | Method of treating or inhibiting anti-arrhythmic events in male human patients | Jul 19, 2004 | Abandoned |
Array
(
[id] => 7127896
[patent_doc_number] => 20050059640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Treatment for reactive arthritis or bursitis'
[patent_app_type] => utility
[patent_app_number] => 10/896612
[patent_app_country] => US
[patent_app_date] => 2004-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2207
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10896612
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/896612 | Treatment for reactive arthritis or bursitis | Jul 19, 2004 | Issued |
Array
(
[id] => 968623
[patent_doc_number] => 06939897
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Method and composition for inhibiting arteriosclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/892164
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2369
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939897.pdf
[firstpage_image] =>[orig_patent_app_number] => 10892164
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/892164 | Method and composition for inhibiting arteriosclerosis | Jul 15, 2004 | Issued |
Array
(
[id] => 7089810
[patent_doc_number] => 20050009923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Bronchodilating beta-agonist compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/887785
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10123
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009923.pdf
[firstpage_image] =>[orig_patent_app_number] => 10887785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/887785 | Bronchodilating β-agonist compositions and methods | Jul 8, 2004 | Issued |
Array
(
[id] => 7276345
[patent_doc_number] => 20040235796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Combinations comprising epothilones and pharmaceutical uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/484482
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6484
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235796.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484482 | Combinations comprising epothilones and pharmaceutical uses thereof | Jul 8, 2004 | Abandoned |
Array
(
[id] => 5739095
[patent_doc_number] => 20060009486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Composition and method for treatment and prevention of coronary artery disease'
[patent_app_type] => utility
[patent_app_number] => 10/886389
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1625
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10886389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/886389 | Composition and method for treatment and prevention of coronary artery disease | Jul 6, 2004 | Abandoned |
Array
(
[id] => 7026991
[patent_doc_number] => 20050020656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Organ fibrosis inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/875274
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6024
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10875274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/875274 | Organ fibrosis inhibitor | Jun 24, 2004 | Issued |
Array
(
[id] => 7083875
[patent_doc_number] => 20050049255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Therapeutic combinations'
[patent_app_type] => utility
[patent_app_number] => 10/865194
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13223
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049255.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865194
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865194 | Therapeutic combinations | Jun 9, 2004 | Abandoned |
Array
(
[id] => 5678422
[patent_doc_number] => 20060183778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Osteogenesis-promotion enhancer and method of screening the same'
[patent_app_type] => utility
[patent_app_number] => 10/559155
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5545
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559155 | Osteogenesis-promotion enhancer and method of screening the same | Jun 6, 2004 | Issued |
Array
(
[id] => 7319286
[patent_doc_number] => 20040224999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Use of angiotensin II receptor antagonists for treating acute myocardial infarction'
[patent_app_type] => new
[patent_app_number] => 10/859776
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5027
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10859776
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/859776 | Use of angiotensin II receptor antagonists for treating acute myocardial infarction | Jun 2, 2004 | Issued |
Array
(
[id] => 7371910
[patent_doc_number] => 20040219137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Method for reducing exacerbations associated with COPD'
[patent_app_type] => new
[patent_app_number] => 10/856460
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3338
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219137.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856460 | Method for reducing exacerbations associated with COPD | May 27, 2004 | Abandoned |
Array
(
[id] => 745243
[patent_doc_number] => 07026342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-11
[patent_title] => 'Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds'
[patent_app_type] => utility
[patent_app_number] => 10/852859
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13461
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 992
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026342.pdf
[firstpage_image] =>[orig_patent_app_number] => 10852859
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/852859 | Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds | May 23, 2004 | Issued |
Array
(
[id] => 7276496
[patent_doc_number] => 20040235947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Neuroprotective composition and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/848752
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10770
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848752 | Neuroprotective composition and uses thereof | May 17, 2004 | Abandoned |
Array
(
[id] => 4746306
[patent_doc_number] => 20080090908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Use of Triglyceride Oils Containing Gamma-Linolenic Acid Residues and Linoleic Acid Residues for the Treatment of Neurodegenerative Disease'
[patent_app_type] => utility
[patent_app_number] => 10/555757
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8070
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090908.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555757 | Use of triglyceride oils containing γ-linolenic acid residues and linoleic acid residues for the treatment of neurodegenerative disease | May 13, 2004 | Issued |
Array
(
[id] => 7428080
[patent_doc_number] => 20040229954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Selective manipulation of triglyceride, HDL and LDL parameters with 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt'
[patent_app_type] => new
[patent_app_number] => 10/844879
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5295
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10844879
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/844879 | Selective manipulation of triglyceride, HDL and LDL parameters with 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt | May 12, 2004 | Abandoned |
Array
(
[id] => 5205630
[patent_doc_number] => 20070027112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions'
[patent_app_type] => utility
[patent_app_number] => 10/555738
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35181
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027112.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555738 | Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions | May 5, 2004 | Issued |
Array
(
[id] => 7467188
[patent_doc_number] => 20040198819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Biological response modifier composition and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/481867
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 22909
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198819.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481867 | Biological response modifier composition and uses thereof | May 2, 2004 | Abandoned |
Array
(
[id] => 745307
[patent_doc_number] => 07026355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-11
[patent_title] => 'Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases'
[patent_app_type] => utility
[patent_app_number] => 10/833593
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 4984
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026355.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833593
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833593 | Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases | Apr 26, 2004 | Issued |